Bioventix PLC (AIM:BVXP)
London · Delayed Price · Currency is GBP · Price in GBX 1,705.00
-25.00 (-1.45%)
Sep 4, 2026, 4:36 PM GMT
Bioventix Income Statement
Financials in millions GBP. Fiscal year is July - June.
Millions GBP. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 12.54 | 13.12 | 13.61 | 12.82 | 11.72 | 10.93 | |
Revenue Growth | -8.21% | -3.61% | 6.17% | 9.36% | 7.22% | 5.98% |
Cost of Revenue | 0.95 | 1.2 | 0.93 | 0.83 | 0.71 | 0.82 |
Gross Profit | 11.59 | 11.92 | 12.68 | 11.99 | 11.01 | 10.11 |
Selling, General & Admin | 2.02 | 2.05 | 1.99 | 1.77 | 1.61 | 1.51 |
Research & Development | -0.29 | -0.3 | -0.03 | -0.03 | -0.02 | -0.03 |
Operating Expenses | 1.82 | 1.84 | 2.05 | 1.92 | 1.83 | 1.73 |
Operating Income | 9.77 | 10.07 | 10.63 | 10.07 | 9.18 | 8.38 |
Interest Expense | - | - | - | - | -0 | - |
Interest & Investment Income | 0.16 | 0.19 | 0.2 | 0.1 | 0 | 0.03 |
Currency Exchange Gain (Loss) | -0.03 | -0.17 | -0.04 | -0.04 | 0.09 | -0.29 |
EBT Excluding Unusual Items | 9.9 | 10.1 | 10.79 | 10.13 | 9.28 | 8.12 |
Gain (Loss) on Sale of Investments | - | - | -0.18 | - | - | - |
Pretax Income | 9.9 | 10.1 | 10.6 | 10.13 | 9.28 | 8.12 |
Income Tax Expense | 2.46 | 2.51 | 2.51 | 1.76 | 1.6 | 1.39 |
Net Income | 7.44 | 7.58 | 8.1 | 8.37 | 7.67 | 6.73 |
Net Income to Common | 7.44 | 7.58 | 8.1 | 8.37 | 7.67 | 6.73 |
Net Income Growth | -5.21% | -6.33% | -3.29% | 9.10% | 14.01% | -6.54% |
Shares Outstanding (Basic) | 5 | 5 | 5 | 5 | 5 | 5 |
Shares Outstanding (Diluted) | 5 | 5 | 5 | 5 | 5 | 5 |
Shares Change | -0.08% | -0.08% | 0.14% | 0.56% | -0.03% | 0.76% |
EPS (Basic) | 1.42 | 1.45 | 1.55 | 1.61 | 1.47 | 1.29 |
EPS (Diluted) | 1.41 | 1.43 | 1.53 | 1.58 | 1.46 | 1.28 |
EPS Growth | -5.13% | -6.26% | -3.42% | 8.48% | 14.04% | -7.24% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Free Cash Flow | 7.77 | 7.01 | 8.33 | 7.79 | 7.55 | 6.08 |
Free Cash Flow Per Share | 1.47 | 1.32 | 1.57 | 1.47 | 1.44 | 1.16 |
Dividend Per Share | 1.500 | 1.500 | 1.550 | 1.520 | 1.260 | 1.050 |
Dividend Growth | -4.46% | -3.23% | 1.97% | 20.64% | 20.00% | 19.32% |
Gross Margin | 92.45% | 90.86% | 93.20% | 93.54% | 93.94% | 92.52% |
Operating Margin | 77.93% | 76.80% | 78.10% | 78.57% | 78.34% | 76.68% |
Profit Margin | 59.30% | 57.83% | 59.51% | 65.33% | 65.48% | 61.58% |
Free Cash Flow Margin | 61.95% | 53.47% | 61.21% | 60.80% | 64.38% | 55.60% |
EBITDA | 9.84 | 10.17 | 10.74 | 10.2 | 9.32 | 8.52 |
EBITDA Margin | 78.45% | 77.51% | 78.93% | 79.58% | 79.56% | 77.92% |
D&A For EBITDA | 0.07 | 0.09 | 0.11 | 0.13 | 0.14 | 0.14 |
EBIT | 9.77 | 10.07 | 10.63 | 10.07 | 9.18 | 8.38 |
EBIT Margin | 77.93% | 76.80% | 78.10% | 78.57% | 78.34% | 76.68% |
Effective Tax Rate | 24.88% | 24.88% | 23.64% | 17.39% | 17.29% | 17.08% |